Drawing for CHROMATONE

USPTO serial 78737514

CHROMATONE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHROMATONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Preston C. Regehr

Preston C. Regehr TechLaw Ventures, PLLC3290 W. Mayflower WayLehi, UT 84043UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements; Herbal supplements; Nutritional supplementsACTIVEJan 24, 1995

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 10, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 19, 2005MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Dec 19, 2005ABN1ABANDONMENT - EXPRESS MAILED—
Dec 16, 2005EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 25, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance